amoxicillin + metronidazole + tetracycline

This is a combination of three antibiotics—amoxicillin, metronidazole, and tetracycline—used primarily in the treatment of Helicobacter pylori (H. pylori) infection and associated peptic ulcer disease. Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis, leading to cell lysis and death. Metronidazole is a nitroimidazole antibiotic effective against anaerobic bacteria and certain protozoa; it disrupts DNA synthesis in susceptible organisms. Tetracycline is a broad-spectrum bacteriostatic antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit of bacteria.

While these agents are often used as part of multi-drug regimens (typically with bismuth compounds and proton pump inhibitors), the specific triple combination of amoxicillin + metronidazole + tetracycline without additional agents is not standard but may be considered in certain clinical scenarios where resistance patterns or patient allergies dictate alternative regimens. The rationale for combining these drugs lies in their complementary mechanisms and low rates of resistance for amoxicillin and tetracycline. However, some studies suggest possible antagonism between bactericidal (amoxicillin) and bacteriostatic (tetracycline) actions when used together.